Abstract
Sequencing of the Mycobacterium tuberculosis pncA gene allows for pyrazinamide susceptibility testing. We summarize data on pncA polymorphisms that do not confer resistance at a susceptibility breakpoint of 100 μg/ml pyrazinamide in MGIT within a cohort of isolates from South Africa and the U.S. Centers for Disease Control and Prevention.
Cite
CITATION STYLE
Whitfield, M. G., Warren, R. M., Streicher, E. M., Sampson, S. L., Sirgel, F. A., Van Helden, P. D., … Posey, J. E. (2015). Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 micrograms per milliliter in MGIT. Journal of Clinical Microbiology, 53(11), 3633–3635. https://doi.org/10.1128/JCM.01001-15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
